ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "race/ethnicity"

  • Abstract Number: 1075 • ACR Convergence 2025

    Racial Differences in Management and Clinical Outcomes of Giant-Cell Arteritis: A Real-World Propensity-Matched Study

    Michael Hamilton1, Justin Riley Lam2, Emmanuel Otabor3, Laith Alomari3, Maxim Barnett3, Fabian Rodriguez Quinonez4 and Irene Tan5, 1Jefferson Einstein Hospital, Philadelphia, Philadelphia, PA, 2Jefferson Einstein Hospital, Philadelphia, PA, 3Jefferson Einstein Hospital Philadelphia, Philadelphia, PA, 4Einstein Medical Center Philadelphia, Philadelphia, PA, 5Einstein Healthcare Network Philadelphia - Jefferson Health, Bala Cynwyd, PA

    Background/Purpose: Giant-cell arteritis (GCA) is usually described in people of Northern-European ancestry, and little is known about outcomes in Black and Hispanic (B-His) patients. Using…
  • Abstract Number: 2120 • ACR Convergence 2025

    Analyzing Gender and Racial Disparities in Paget’s Disease of Bone: A Large-Scale Observational Study

    Kinga Grzybowski1, Ahmer Khan2 and Arthur Lau3, 1Jefferson Einstein Montgomery Hospital, Maspeth, NY, 2Jefferson Einstein Philadelphia Hospital, Philadelphia, 3Jefferson Einstein Hospital, Maple Glen, PA

    Background/Purpose: Osteitis deformans, commonly referred to as Paget’s Disease of the Bone (PDB), affects adults over the age of 55, mainly of European descent and…
  • Abstract Number: 1074 • ACR Convergence 2025

    Racial Disparities in Cardiovascular, Ocular, and Treatment Outcomes in US Patients with Behçet’s Disease: A Propensity-Matched Real-World Analysis

    Michael Hamilton1, Justin Riley Lam2, Emmanuel Otabor3, Laith Alomari3, Maxim Barnett3, Shahrzad Abdollahi2 and Irene Tan4, 1Jefferson Einstein Hospital, Philadelphia, Philadelphia, PA, 2Jefferson Einstein Hospital, Philadelphia, PA, 3Jefferson Einstein Hospital Philadelphia, Philadelphia, PA, 4Einstein Healthcare Network Philadelphia - Jefferson Health, Bala Cynwyd, PA

    Background/Purpose: Racial/ethnic disparities in Behçet’s disease (BD) outcomes are largely undocumented in the United States. Given known differences in disease expression across populations globally, we…
  • Abstract Number: 2088 • ACR Convergence 2025

    Aging Unevenly: National Trends and Inequities in Osteoarthritis Mortality, 1999–2020

    Ghassan Makhoul1, Aziz-ur-Rahman Khalid2, Hasan Munshi1, Islam Rajab1, MD Walid Akram Hussain1, Reshma John1, Elvira Assaf1, Amer Al Badawy1, Barbare Khatiashvili1, Rouba Isshak1, Nargis Mateen3 and Robert Lahita4, 1St. Josephs University Medical Center, Paterson, 2St. Joseph's University Medical Center, wayne, 3St. Josephs University Medical Center, Paterson, NJ, 4St. Josephs University Medical Center, Wayne, NJ

    Background/Purpose: Osteoarthritis (OA) is a leading cause of disability and pain in older adults. While not traditionally viewed as fatal, OA contributes significantly to morbidity…
  • Abstract Number: 1073 • ACR Convergence 2025

    Development of a Culturally-Tailored Storytelling Intervention to Improve COVID-19 Vaccine Uptake in Black and Latinx Patients with Autoimmune and Inflammatory Rheumatic Diseases

    Maria I. ("Maio") Danila1, Lesley Jackson2, Stephanie Ford3, Mary Wilkenson3, Tiffany Alexander4, Jeroan Allison5, Candace Feldman6, Fred Jenoure7, Jonathan Kay5, Stephenie Lemon8, Kenneth Saag9, Karen Salomon10 and Shilpa Venkatachalam11, 1University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3UAB Division of Clinical Immunology and Rheumatology, Birmingham, AL, 4Community Investigator- AL, Birmingham, AL, 5UMass Chan Medical School, Worcester, MA, 6Brigham and Women's Hospital, Boston, MA, 7Community Investigator- MA, Worcester, MA, 83. Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, Worcester, MA, 9The University of Alabama at Birmingham, Birmingham, AL, 10University of Massachusetts Medical School, Shrewsbury, MA, 11Global Healthy Living Foundation, New York, NY

    Background/Purpose: Black and Latinx individuals with autoimmune and inflammatory rheumatic diseases (AIRD) face disproportionately higher risks of severe COVID-19 outcomes. Despite this elevated risk, vaccine…
  • Abstract Number: 0174 • ACR Convergence 2024

    A Nationwide Analysis of Gender and Racial Disparities in Patients with Systemic Sclerosis and Acute Coronary Syndrome

    Omair Khan1, Kundan Jana2, Azka Naeem2, Syed Mujtaba Baqir2, Marlon Rivera Boadla2, Muhammad Hashim khan2 and Vijay Shetty2, 1Maimonides Medical Center, Council Bluffs, IA, 2Maimonides Medical Center, Brooklyn, NY

    Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune condition characterized by widespread skin fibrosis and/or end-organ damage. Previous studies have reported variable outcomes of the disease…
  • Abstract Number: 1016 • ACR Convergence 2024

    Pharmacoequity of DMARDs Among Adults with Rheumatoid Arthritis in the U.S

    Ashkan Ara1, Matthew Chenoweth2, Srikanth Kadiyala2, Utibe Essien3 and Christopher Scannell3, 1Division of Rheumatology, David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, 2Department of Health Policy and Management, Fielding School of Public Health at UCLA, Los Angeles, 3Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles

    Background/Purpose: Long-term management of rheumatoid arthritis (RA) relies on disease-modifying antirheumatic drugs (DMARDs), including conventional synthetic (csDMARDs), biologic (bDMARDs), and targeted synthetic (tsDMARDs). About 40%…
  • Abstract Number: 1921 • ACR Convergence 2024

    Devastating Morbidity and Mortality Rates in the Hmong Population with a Diagnosis of Gout Who Had a COVID-19 Infection

    Kari Falaas1, Michael Schnaus2, Margaret Singer3, Allison Hochstetler3, Pang Nhia Khang4, Katherine Schmiechen4 and Elie Gertner3, 1University of Minnesota, Regions Hospital, Minneapolis, MN, 2University of Minnesota, Regions Hospital, Methodist Hospital, Minneapolis, 3University of Minnesota, Regions Hospital, Minneapolis, 4Regions Hospital, Minneapolis

    Background/Purpose: Hyperuricemia is associated with an elevated risk of developing cardiovascular diseases, diabetes, chronic kidney disease, and metabolic syndromes. The Hmong population, in particular, has…
  • Abstract Number: 0176 • ACR Convergence 2024

    Race-Based Differences in Immune Responses Following an Episode of Acute Low Back Pain Among Those Who Develop Chronic LBP and Those Who Do Not

    Colleen Burke1, Michael Brown2, Rebecca Fillipo3, Stephanie Danyluk2, Kelley Seebeck2 and Adam Goode2, 1Duke University School of Medicine, Chapel Hill, NC, 2Duke University, Durham, NC, 3Duke University School of Medicine, Durham, NC

    Background/Purpose: Acute low back pain (LBP) affects over 25% of adults annually in the United States, and as many as one-third of these individuals will…
  • Abstract Number: 1030 • ACR Convergence 2024

    Diversity in Axial Spondyloarthritis Drug Trials: Examining Enrollment by Sex, Race, Ethnicity and Geographic Region

    Mathieu Choufani1, Wissam Ghusn2 and Joerg Ermann3, 1Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, 2Department of Internal Medicine, Boston Medical Center, Boston, MA, 3Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: While axial spondyloarthritis (AxSpA) was historically perceived as a "white man's disease", it is now appreciated as a condition that can affect individuals of…
  • Abstract Number: 1924 • ACR Convergence 2024

    Racial and Gender Disparities in Psoriatic Arthritis Clinical Trials

    Dania Kaur1, Fizza Zulfiqar2, Akshee Batra3 and Abhinav Vyas4, 1North Alabama Medical Center, Muscle Shoals, AL, 2Trinity Health Oakland/Wayne State University, Pontiac, MI, 3University of Miami, Miami, FL, 4Vanderbilt University Medical Center, Nahville, TN

    Background/Purpose: To develop effective novel treatment strategies for psoriatic arthritis that cater to patients from diverse backgrounds, it is crucial that all racial groups, without…
  • Abstract Number: 0180 • ACR Convergence 2024

    Collaborative Solutions to Lupus Trial Challenges for Underrepresented Participant Recruitment & Engagement: Perspectives from the Lupus Clinical Investigators Network (LuCIN)

    Brandon Jackson1, Maria Dall'Era2, Saira Sheikh3, Xueting Zhang4, Taylor Irons5, Claire Finney6, Taylor Adjei7, Jennifer Meriwether7, Caroline Donovan8, Carla Menezes9 and Stacie Bell10, 1Lupus Research Alliance / Lupus Therapeutics, Miami, FL, 2UCSF, Corte Madera, CA, 3University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Weill Cornell, New York, NY, 5Lupus Research Alliance / Lupus Therapeutics, Houston, 6Lupus Research Alliance / Lupus Therapeutics, Birmingham, AL, 7Lupus Research Alliance / Lupus Therapeutics, New York, NY, 8Lupus Research Alliance / Lupus Therapeutics, Arlington, VA, 9Lupus Research Alliance / Lupus Therapeutics, Brooklyn, NY, 10Lupus Therapeutics, Lakewood, CO

    Background/Purpose: Racial and ethnic minority groups face higher lupus prevalence and severity and remain inadequately represented in lupus clinical trials. Lupus Therapeutics, the clinical affiliate…
  • Abstract Number: 1033 • ACR Convergence 2024

    Osteoporosis and Cardiovascular Disease: Mortality Trends Among Adults in the United States from 1999 to 2020

    Muhammad Naveed1, Farman Ali2, Ahila Ali1, Bazil Azeem3, Faizan Ahmed4, Rabia Iqbal1, Muhammad Omer Rehan1, Nouman Shafique5, Syed Ishaq6, Aman Ullah7 and Sherif Eltawansy8, 1Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan, 2Corewell Health, Dearborn Hospital, Dearborn, MI, Dearborn, MI, 3Shaheed Mohtarma Benazir Bhutto Medical College Liyari, Karachi, Pakistan, 4Ameer-ud-Din Medical College, Lahore, Pakistan, 5AdventHealth Orlando, Orlando, FL, 6Sinai Hospital of Baltimore, Baltimore, MD, 7SSM Health St Louis University Hospital, St. Louis, MO, 8Jersey Shore University Medical Centre, Neptune, NJ

    Background/Purpose: Osteoporosis and cardiovascular disease (CVD) represent significant public health concerns. This study investigates the trends and demographic disparities in mortality due to osteoporosis and…
  • Abstract Number: 2313 • ACR Convergence 2024

    Race and Ethnicity as Predictors of Diagnostic Delay in Psoriatic Arthritis and Axial Spondyloarthritis

    Christine Loftis1, Liron Caplan2, Joanna Padilla Zepeda3, Nicole Mukooba3, Mayan Caplan3, Meika Fang4, Liya Stolyar5, Jessica Walsh6, Gail Kerr7, Siba Raychaudhuri8, Andreas Reimold9 and Maida Wong10, 1University of Colorado Anschutz School of Medicine, Aurora, CO, 2Univ of Colorado School of Medicine/Rocky Mtn Regional Veterans Affairs Medical Center, Aurora, CO, 3University of Colorado, Aurora, CO, 4Veterans Affairs, Los Angeles, 5Veterans Affairs, Palo Alto, 6Veterans Affairs, Salt Lake City, UT, 7Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 8Veterans Affairs, Sacramento, 9University of Texas Southwestern Medical School, Dallas, 10Veterans Affairs, Long Beach

    Background/Purpose: Studies have suggested a delay between symptom onset and diagnosis for Psoriatic Arthritis (PsA) and axial spondyloarthritis (axSpA).  Factors that influence this delay have…
  • Abstract Number: 0183 • ACR Convergence 2024

    Sensitivity of 2019 EULAR/ACR SLE Criteria and Initial Organ Manifestations for Black and Hispanic Children with Juvenile Systemic Lupus Erythematosus (jSLE) at a Large Tertiary Care Center

    Michelle Butts1, Emily Beil1, Danielle Guffey2, Andrea Ramirez1, Cagri Yildirim-Toruner3, Erin Peckham-Gregory1 and Marietta De Guzman1, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, 3Baylor College of Medicine/ Texas Children's Hospital, Houston, TX

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disorder with diverse features, posing classification challenges. In 2019, EULAR and ACR developed new classification criteria to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology